• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconsanofi

sanofi

Page 2 of 6
Minnesotans can buy insulin for just $35 a month over the next 5 years under a state settlement with Eli Lilly
HealthMinnesotans can buy insulin for just $35 a month over the next 5 years under a state settlement with Eli Lilly
By Steve Karnowski and The Associated PressFebruary 8, 2024
person standing in front of a countdown clock in front of Paris's Eiffel Tower
LifestyleGen X drugmaker is coughing up millions for Paris Olympics sponsorship to show Gen Z and millennials it’s a cool place to work
By Prarthana PrakashJanuary 10, 2024
McLaren Racing boss Zak Brown
LeadershipHow the high-stakes world of Formula 1 racing inspired Sanofi CEO Paul Hudson to deliver more medicines
By Christiaan HetznerNovember 27, 2023
U.S. cancer patients face nationwide shortages of life-saving chemo drugs as ‘race to the bottom’ makes their production unprofitable
HealthU.S. cancer patients face nationwide shortages of life-saving chemo drugs as ‘race to the bottom’ makes their production unprofitable
By Christiaan HetznerOctober 28, 2023
Paul Hudson
SuccessGen Z needs brand-new skills to climb to the C-suite: ‘What got me here will not get them there,’ says health care CEO
By Jane ThierJune 2, 2023
Sanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’
CommentarySanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’
By Paul HudsonMay 17, 2023
Zara Summers, vice president of science at LanzaTech.
CommentarySynthetic biology could disrupt some of the world’s biggest industries. Here are four steps to building a ‘syn-bio’ strategy
By François Candelon, Nicolas Goeldel and Max MännigMarch 3, 2023
Albert Bourla, chairman and chief executive officer of Pfizer Inc., speaks during South By Southwest.
HealthThe most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By Sy Mukherjee and IDEA PharmaApril 20, 2022
Gloved hand holding pills in front of Sanofi corporate logo
HealthSanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By Jeremy KahnJanuary 7, 2022
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
MagazineInsulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
By Geoff ColvinDecember 6, 2021
In this photo illustration a medical syringe seen displayed in front of the Sanofi logo.
HealthIts COVID-19 vaccine bogged down in trials, Sanofi to manufacture BioNTech/Pfizer doses
By David MeyerSeptember 10, 2021
Moderna vaccine
HealthBooster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By Sy MukherjeeAugust 5, 2021
An employee checks bottles of diluent inside the pharmaceutical plant Fareva in Poce-sur-Cisse, Central France, on April 22, 2021. Fareva was chosen as the main supplier of the candidate RNA messenger vaccine from the German company CureVac. The site will therefore produce the diluent used in this vaccine.
HealthThese four COVID-19 vaccines could soon join the pandemic fight
By David MeyerMay 8, 2021
Laggard Sanofi says its vaccine still has a role to play in fighting COVID-19
HealthLaggard Sanofi says its vaccine still has a role to play in fighting COVID-19
By Tim Loh and BloombergApril 28, 2021
Sanofi and GSK to restart trial of COVID-19 vaccine after delay
HealthSanofi and GSK to restart trial of COVID-19 vaccine after delay
By Tim Loh, Suzi Ring and BloombergFebruary 22, 2021
1
  • 1
  • 2
  • 3
  • 4
  • 5
6
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.